- Home
- SVA vs CCCS Comparison
SVA vs CCCS Comparison
Compare SVA & CCCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVA
- CCCS
- Stock Information
- Founded
- SVA N/A
- CCCS 1980
- Country
- SVA
- CCCS United States
- Employees
- SVA 3261
- CCCS N/A
- Industry
- SVA
- CCCS Computer Software: Prepackaged Software
- Sector
- SVA
- CCCS Technology
- Exchange
- SVA NYSE
- CCCS Nasdaq
- Market Cap
- SVA N/A
- CCCS 7.0B
- IPO Year
- SVA N/A
- CCCS N/A
- Fundamental
- Price
- SVA $6.47
- CCCS $11.32
- Analyst Decision
- SVA
- CCCS Buy
- Analyst Count
- SVA 0
- CCCS 7
- Target Price
- SVA N/A
- CCCS $13.86
- AVG Volume (30 Days)
- SVA N/A
- CCCS 2.3M
- Earning Date
- SVA N/A
- CCCS 10-28-2024
- Dividend Yield
- SVA N/A
- CCCS N/A
- EPS Growth
- SVA N/A
- CCCS N/A
- EPS
- SVA N/A
- CCCS 0.03
- Revenue
- SVA N/A
- CCCS $909,603,000.00
- Revenue This Year
- SVA N/A
- CCCS $11.07
- Revenue Next Year
- SVA N/A
- CCCS $8.60
- P/E Ratio
- SVA N/A
- CCCS $369.30
- Revenue Growth
- SVA N/A
- CCCS 11.00
- 52 Week Low
- SVA N/A
- CCCS $9.79
- 52 Week High
- SVA N/A
- CCCS $12.68
- Technical
- Relative Strength Index (RSI)
- SVA N/A
- CCCS 66.82
- Support Level
- SVA N/A
- CCCS $10.60
- Resistance Level
- SVA N/A
- CCCS $11.02
- Average True Range (ATR)
- SVA 0.00
- CCCS 0.20
- MACD
- SVA 0.00
- CCCS 0.06
- Stochastic Oscillator
- SVA 0.00
- CCCS 94.00
About SVA SINOVAC BIOTECH LTD
Sinovac Biotech Ltd is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease (HFMD) caused by EV71, seasonal influenza, H5N1 and H1N1 pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps.
About CCCS CCC Intelligent Solutions Holdings Inc.
CCC Intelligent Solutions Holdings Inc is a provider of cloud, mobile, AI, telematics, hyperscale technologies and applications for the property and casualty insurance economy. The company's SaaS platform connects trading partners, facilitates commerce, and supports mission-critical, and AI-enabled digital workflows. The company generate revenue through the sale of software subscriptions and other revenue, primarily from professional services. The company has its presence in United States and China. Majority of the revenue is generated from United States.